ABCL
AbCellera Biologics Inc.
NASDAQ · Healthcare · Biotechnology · CA
$11.43
−1.21%4
Insider buys (3m)
0
Insider sells (3m)
$1.5M
Net value (3m)
+102.6%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 24, 2026 | Hayden Michael R · director | Purchase | 53,613 | $11 |
| Aug 18, 2026 | Montalbano John S. · director | Purchase | 10,000 | $11 |
| Aug 14, 2026 | Booth Andrew · officer: Chief Financial Officer | Purchase | 37,200 | $10 |
| Aug 14, 2026 | Hayden Michael R · director | Purchase | 46,387 | $10 |
| Jul 6, 2026 | Sandor Victor · director | A-Award | 152,207 | $7.85 |
| Jul 6, 2026 | Seely Lynn · director | A-Award | 152,207 | $7.85 |
| Jun 12, 2026 | Hayden Michael R · director | A-Award | 111,701 | $5.27 |
| Jun 12, 2026 | Quake Stephen · director | A-Award | 111,701 | $5.27 |
| Jun 12, 2026 | Montalbano John S. · director | A-Award | 111,701 | $5.27 |
| May 18, 2026 | Montalbano John S. · director | Purchase | 20,000 | $4.77 |
| Mar 2, 2026 | Thermopylae Holdings Ltd. · 10 percent owner | Purchase | 38,000 | $3.44 |
| Feb 27, 2026 | Thermopylae Holdings Ltd. · 10 percent owner | Purchase | 177,457 | $3.27 |
| Feb 27, 2026 | Booth Andrew · officer: Chief Financial Officer | Purchase | 42,600 | $3.42 |
| Jan 5, 2026 | Hansen Carl L. G. · director, 10 percent owner, officer: Chief Executive Officer | A-Award | 2,106,505 | $3.42 |
| Jan 5, 2026 | Lecault Veronique · director, officer: Chief Technology Officer | A-Award | 539,265 | $3.42 |
| Jan 5, 2026 | Booth Andrew · officer: Chief Financial Officer | A-Award | 808,898 | $3.42 |
| Jan 5, 2026 | Stimart Tryn · officer: Chief Legal Officer | A-Award | 539,265 | $3.42 |
| Dec 19, 2025 | Quake Stephen · director | A-Award | 194,932 | $3.47 |
| Nov 26, 2025 | Montalbano John S. · director | Purchase | 50,000 | $3.57 |
| Jul 1, 2025 | Hayden Michael R · director | A-Award | 238,864 | $3.15 |
| Jun 16, 2025 | Montalbano John S. · director | A-Award | 238,864 | $3.15 |
| Jun 16, 2025 | Lo Andrew · director | A-Award | 238,864 | $3.15 |
| Mar 11, 2025 | Thermopylae Holdings Ltd. · 10 percent owner | Purchase | 343,631 | $2.16 |
| Mar 10, 2025 | Montalbano John S. · director | Purchase | 25,000 | $2.30 |
| Mar 7, 2025 | Montalbano John S. · director | Purchase | 60,000 | $2.34 |
| Jan 3, 2025 | Stimart Tryn · officer: Chief Legal Officer | A-Award | 832,033 | $2.93 |
| Jan 3, 2025 | Lecault Veronique · director, officer: Chief Operating Officer | A-Award | 832,033 | $2.93 |
| Jan 3, 2025 | Hansen Carl L. G. · director, 10 percent owner, officer: Chief Executive Officer | A-Award | 2,730,109 | $2.93 |
| Jan 3, 2025 | Booth Andrew · officer: Chief Financial Officer | A-Award | 1,352,054 | $2.93 |
| Nov 26, 2024 | Hansen Carl L. G. · director, 10 percent owner, officer: Chief Executive Officer | M-Exempt | 56,125 | $2.70 |
Institutional positioning
13F filings over the trailing two quarters
New 20Increased 57Reduced 38Sold out 138
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BAKER BROS. ADVISORS LP | Increased | 30,275,938 | May 15, 2026 |
| CAPITAL WORLD INVESTORS | Unchanged | 13,361,096 | May 13, 2026 |
| TWO SIGMA INVESTMENTS, LP | Increased | 10,562,065 | May 15, 2026 |
| TD WATERHOUSE CANADA INC. | Increased | 9,564,659 | May 12, 2026 |
| UBS ASSET MANAGEMENT AMERICAS INC | Reduced | 7,575,476 | May 13, 2026 |
| JEFFERIES FINANCIAL GROUP INC. | New Position | 5,482,400 | May 8, 2026 |
| GOLDMAN SACHS GROUP INC | Increased | 4,344,485 | Mar 25, 2026 |
| UBS GROUP AG | Increased | 4,209,052 | May 5, 2026 |
| ARROWMARK COLORADO HOLDINGS LLC | Unchanged | 4,105,095 | May 15, 2026 |
| BLACKROCK, INC. | Increased | 4,040,236 | May 13, 2026 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | Increased | 4,024,779 | May 15, 2026 |
| GOLDMAN SACHS GROUP INC | Reduced | 3,751,212 | May 15, 2026 |
| BANK OF AMERICA CORP /DE/ | Increased | 2,999,936 | May 18, 2026 |
| CITADEL ADVISORS LLC | Increased | 2,749,112 | Sep 2, 2026 |
| ALYESKA INVESTMENT GROUP, L.P. | New Position | 2,592,105 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 24, 2026